Skip to content
DE

Vitamin B12: Reference ranges, thresholds, and follow-up tests

Clinical review pending

A normal vitamin B12 result does not answer every question. Learn how reference ranges, symptoms, and follow-up tests help put it in context.

A hand holds an open blank book with three colored windows.

A vitamin B12 result is interpreted alongside symptoms, risk factors, and the laboratory method used. There is no generally accepted “optimal” level of at least 542 pg/mL. For a borderline result, methylmalonic acid (MMA) can help with assessment; kidney function also affects this marker. Unexpectedly high B12 needs to be considered in relation to supplements and possible medical conditions.

What vitamin B12 does and how laboratories measure it

Vitamin B12, or cobalamin, is needed for nerve function, red blood cell formation, and DNA synthesis. A serum B12 test measures the total amount circulating in the blood. Source 1

Before cells can use vitamin B12 from food, it must first be released from food proteins. The usual absorption pathway requires intrinsic factor, a protein made in the stomach; B12 is then carried onward bound to transport proteins. Source 1

Laboratories report serum B12 in pg/mL or pmol/L: 200 pg/mL and 148 pmol/L describe the same concentration. A comparison range helps with interpretation. A laboratory reference interval is neither a personal treatment target nor evidence that higher levels are better. Source 1

Normal versus supposedly optimal vitamin B12 ranges

MedlinePlus gives 299–1,054 pg/mL (219–773 pmol/L) as an example, while noting that ranges differ between laboratories. An observational study in middle-aged and older adults found rising MMA at B12 levels below around 400 pmol/L, or approximately 542 pg/mL. That is a statistical association, not an established treatment target. Age and kidney function also influenced MMA. Source 1 Source 2

The lower cutoff varies by laboratory and is usually 200 or 250 pg/mL; there is no single clear threshold that applies universally. Source 1 Source 2

Category Serum B12 (pg/mL) Serum B12 (pmol/L) Meaning
Low level in U.S. surveys Below 200 Below 148 Commonly used threshold; symptoms and testing method also matter clinically
Intermediate range in U.S. surveys 200–299 148–220 Epidemiological category, not a clinical diagnosis on its own
Laboratory reference interval 299–1,054 219–773 One laboratory’s normal interval; results within it are not flagged as abnormal
Research observation, not a treatment target About 542 About 400 Statistical association with MMA; not a generally accepted optimum
Above the reference interval Above 1,054 Above 773 Above this laboratory’s normal range, with various possible causes

Table sources: Source 1 Source 2 Source 3

Thresholds depend on the testing method. For total B12, NICE uses below 180 pg/mL as an indication of deficiency and 180–350 pg/mL as an indeterminate range, while allowing validated laboratory-specific thresholds. This illustrates why a single research value should not become a universal target. Source 1

Why a normal B12 result may not tell the whole story

Inadequate B12 availability can occur despite a normal serum result because the test measures all circulating B12. Only about a quarter circulates as active B12, the fraction available to cells. Source 1

In an observational study of 231 healthy older adults, lower B12 within the reference range was associated with some less favorable neurological measurements. The study does not show that supplements prevent or improve these changes in people without a diagnosed deficiency. Source 1

Low B12 can cause fatigue, numbness, or tingling in the hands and feet. These neurological symptoms can occur without anemia. The serum result alone is therefore not always enough for assessment. Source 1

Which tests help clarify a borderline result?

A borderline serum B12 result can be easier to interpret alongside a metabolic marker that accumulates when cells lack B12. Source 1

An analysis of older U.S. surveys placed roughly one-third of the adults studied in a statistically indeterminate intermediate range. This is not a current estimate of clinical deficiency prevalence. Depending on the situation, total or active B12 can now serve as the initial test; MMA may help clarify an uncertain result when relevant symptoms are present. Source 1 Source 2

Test What it measures How it complements serum B12
Methylmalonic acid (MMA) A metabolite that can rise with B12 deficiency A sensitive marker used to help confirm deficiency when serum B12 is 150–399 pg/mL; age and kidney function matter for interpretation
Homocysteine A metabolite that can rise with B12 or folate deficiency, among other causes Useful, but less specific than MMA
Holotranscobalamin (active B12) The fraction of B12 that cells can take up In comparative studies it identified elevated MMA better than total B12, although an indeterminate range may remain
Mean corpuscular volume (MCV) in a blood count The average size of red blood cells May indicate macrocytic anemia; a normal value does not rule out B12 deficiency

Table sources: Source 1 Source 2 Source 3 Source 4

These tests help clarify low or borderline results, while a high result prompts consideration of other explanations.

What a high vitamin B12 level means

A high B12 result is not a diagnosis. Supplements or injections often explain it. If it stays elevated without that explanation, it warrants medical interpretation; liver, kidney, or certain blood disorders are among the possibilities. A high result alone means neither cancer nor particularly good B12 status. Source 1

High-dose supplements and injections raise total B12, limiting what the test can tell you during their use. Elevated serum B12 is also associated with liver diseases such as cirrhosis or hepatitis and with myeloproliferative disorders, in which bone marrow produces too many blood cells. Source 1 Source 2

Occasionally, functional problems with cellular uptake or use can coexist with high serum levels. This is a reason to assess conflicting results together with symptoms, rather than to order additional tests for every high measurement. Source 1

Who is more likely to have low B12?

Inadequate B12 most often arises when intestinal absorption or intake falls. In the U.S. survey data cited by NIH, approximately 12.5% of adults had levels below 300 pg/mL; that threshold is not itself a diagnosis of clinical deficiency. Source 1

  • Older adults: Atrophic gastritis reduces the stomach acid needed to release B12 from food. One study found it in 15% of adults aged 60 or older. Source 1

  • Vegans and vegetarians: Deficiency is reported more frequently in vegans than in other vegetarians. Source 1

  • Acid-suppressing drugs and metformin: At least two years of acid-suppressing medication use was associated with deficiency. For metformin, an association was observed with each additional year of use. Source 1 Source 2

  • Gastrointestinal conditions and surgery: Pernicious anemia, celiac disease, weight-loss surgery, and other stomach operations can reduce absorption. Source 1

  • Pregnancy: Serum B12 tends to decline as pregnancy progresses. Source 1

For these groups, adequate intake and targeted investigation of symptoms are particularly important. New numbness, unsteadiness when walking, or marked weakness should receive prompt medical attention. When B12 deficiency with neurological involvement is strongly suspected, treatment should not be delayed while awaiting further results. A vegan diet requires a reliable B12 source through suitable supplements or fortified foods.

References

  • Office of Dietary Supplements. Vitamin B12: fact sheet for health professionals. National Institutes of Health. Updated July 2, 2025. Accessed October 17, 2026. Source

  • Sobczyńska-Malefora A, Delvin E, McCaddon A, Ahmadi KR, Harrington DJ. Vitamin B12 status in health and disease: a critical review. Diagnosis of deficiency and insufficiency – clinical and laboratory pitfalls. Crit Rev Clin Lab Sci. 2021;58(6):399-429. https://doi.org/10.1080/10408363.2021.1885339 Source

  • MedlinePlus. Vitamin B12 level. National Library of Medicine. Reviewed January 10, 2026. Accessed October 17, 2026. Source

  • Vogiatzoglou A, Oulhaj A, Smith AD, et al. Determinants of plasma methylmalonic acid in a large population: implications for assessment of vitamin B12 status. Clin Chem. 2009;55(12):2198-2206. https://doi.org/10.1373/clinchem.2009.128678 Source

  • Devalia V, Hamilton MS, Molloy AM; British Committee for Standards in Haematology. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014;166(4):496-513. https://doi.org/10.1111/bjh.12959 Source

  • Nexo E, Hoffmann-Lücke E. Holotranscobalamin, a marker of vitamin B-12 status: analytical aspects and clinical utility. Am J Clin Nutr. 2011;94(1):359S-365S. https://doi.org/10.3945/ajcn.111.013458 Source

  • Beaudry-Richard A, Abdelhak A, Saloner R, et al. Vitamin B12 levels association with functional and structural biomarkers of central nervous system injury in older adults. Ann Neurol. 2025;97(6):1190-1204. https://doi.org/10.1002/ana.27200 Source

  • Nexo E, Parkner T. Vitamin B12-related biomarkers. Food Nutr Bull. 2024;45(1 suppl):S28-S33. https://doi.org/10.1177/03795721241227114 Source

  • Bailey RL, Durazo-Arvizu RA, Carmel R, et al. Modeling a methylmalonic acid-derived change point for serum vitamin B-12 for adults in NHANES. Am J Clin Nutr. 2013;98(2):460-467. https://doi.org/10.3945/ajcn.113.061234 Source

  • Andrès E, Serraj K, Zhu J, Vermorken AJ. The pathophysiology of elevated vitamin B12 in clinical practice. QJM. 2013;106(6):505-515. https://doi.org/10.1093/qjmed/hct051 Source

  • Porter KM, Hoey L, Hughes CF, et al. Associations of atrophic gastritis and proton-pump inhibitor drug use with vitamin B-12 status, and the impact of fortified foods, in older adults. Am J Clin Nutr. 2021;114(4):1286-1294. https://doi.org/10.1093/ajcn/nqab193 Source

  • Pawlak R, Lester SE, Babatunde T. The prevalence of cobalamin deficiency among vegetarians assessed by serum vitamin B12: a review of literature. Eur J Clin Nutr. 2014;68(5):541-548. https://doi.org/10.1038/ejcn.2014.46 Source

  • Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013;310(22):2435-2442. https://doi.org/10.1001/jama.2013.280490 Source

  • Aroda VR, Edelstein SL, Goldberg RB, et al. Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab. 2016;101(4):1754-1761. https://doi.org/10.1210/jc.2015-3754 Source

  • Sukumar N, Rafnsson SB, Kandala NB, Bhopal R, Yajnik CS, Saravanan P. Prevalence of vitamin B-12 insufficiency during pregnancy and its effect on offspring birth weight: a systematic review and meta-analysis. Am J Clin Nutr. 2016;103(5):1232-1251. https://doi.org/10.3945/ajcn.115.123083 Source

  • NICE. Vitamin B12 deficiency in over 16s: diagnosis and management (NG239). https://www.nice.org.uk/guidance/ng239/chapter/recommendations